Biotie Therapies Corp Stock

Equities

Delayed Nasdaq Helsinki Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

Duration

Period

Style

Biotie Therapies : ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST	16-09-30	GL
Biotie Therapies : ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED	16-09-26	GL
Biotie: BTT1023 receives Orphan Drug Designation in the United States	16-08-26	GL
Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.	16-08-25	GL
Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI	16-08-18	GL

Wall Street finit en hausse avec les ventes au détail	15-06-11
Wall Street finit en hausse avec les ventes au détail	15-06-11
DJ Industrial : Wall Street finit en hausse avec les ventes au détail	15-06-11

Managers	Title	Age	Since
Antero Kallio CEO	Chief Executive Officer	64	05-05-31

Members of the board	Title	Age	Since
Ronald Cohen CHM	Chairman	68	16-04-30
Jane Wasman BRD	Director/Board Member	67	16-04-30
Andrew Hindman BRD	Director/Board Member	51	16-11-30

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.73B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B